Literature DB >> 25128818

Dose-dependent clearance kinetics of intratracheally administered titanium dioxide nanoparticles in rat lung.

Naohide Shinohara1, Yutaka Oshima2, Toshio Kobayashi2, Nobuya Imatanaka3, Makoto Nakai2, Takayuki Ichinose4, Takeshi Sasaki5, Guihua Zhang6, Hiroko Fukui6, Masashi Gamo6.   

Abstract

AEROSIL(®) P25 titanium dioxide (TiO2) nanoparticles dispersed in 0.2% disodium phosphate solution were intratracheally administered to male F344 rats at doses of 0 (control), 0.375, 0.75, 1.5, 3.0, and 6.0 mg/kg. The rats were sacrificed under anesthesia at 1 day, 3 days, 7 days, 4 weeks, 13 weeks, and 26 weeks after administration. Ti levels in various pulmonary and extrapulmonary organs were determined using sensitive inductively coupled plasma sector field mass spectrometry. One day after administration, the lungs contained 62-83% of TiO2 administered dose. Twenty-six weeks after administration, the lungs retained 6.6-8.9% of the TiO2 administered at the 0.375, 0.75, and 1.5 mg/kg doses, and 13% and 31% of the TiO2 administered at the 3.0 and 6.0 mg/kg doses, respectively. The pulmonary clearance rate constants from compartment 1, k1, were estimated using a 2-compartment model and were found to be higher for the 0.375 and 0.75 mg/kg doses of TiO2 (0.030/day for both) than for TiO2 doses of 1.5-6.0 mg/kg (0.014-0.022/day). The translocation rate constants from compartment 1 to 2, k12, were estimated to be 0.015 and 0.018/day for the 0.375 and 0.75 mg/kg doses, and 0.0025-0.0092/day for doses of 1.5-6.0mg/kg. The pulmonary clearance rate constants from compartment 2, k2, were estimated to be 0.0086 and 0.0093/day for doses of 0.375 and 0.75 mg/kg, and 0-0.00082/day for 1.5-6.0 mg/kg doses. Translocation of TiO2 from the lungs to the thoracic lymph nodes increased in a time- and dose-dependent manner, accounting for 0.10-3.4% of the administered dose at 26 weeks. The measured thoracic lymph node burdens were a much better fit to the thoracic lymph node burdens estimated assuming translocation from compartment 1 to the thoracic lymph nodes, rather than those estimated assuming translocation from compartment 2 to the thoracic lymph nodes. The translocation rate constants from the lungs to the thoracic lymph nodes, kLung→Lym, were 0.000037-0.00081/day, and these also increased with increasing doses of TiO2. Although a small amount of TiO2 had translocated to the liver by 3 days after the administration (0.0023-0.012% of the highest dose administered, 6.0 mg/kg), translocation to the other extrapulmonary organs was not detected.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Clearance; Compartment model; Distribution; Nanomaterial; Overload; Toxicokinetics

Mesh:

Substances:

Year:  2014        PMID: 25128818     DOI: 10.1016/j.tox.2014.08.003

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  9 in total

1.  TiO2 Nanoparticles Caused DNA Damage in Lung and Extra-Pulmonary Organs Through ROS-Activated FOXO3a Signaling Pathway After Intratracheal Administration in Rats.

Authors:  Bin Han; Zijie Pei; Lei Shi; Qian Wang; Chen Li; Boyuan Zhang; Xuan Su; Ning Zhang; Lixiao Zhou; Bo Zhao; Yujie Niu; Rong Zhang
Journal:  Int J Nanomedicine       Date:  2020-08-21

2.  Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates.

Authors:  Jing Xu; Mengxiao Yu; Chuanqi Peng; Phoebe Carter; Jia Tian; Xuhui Ning; Qinhan Zhou; Qiu Tu; Greg Zhang; Anthony Dao; Xingya Jiang; Payal Kapur; Jer-Tsong Hsieh; Xudong Zhao; Pengyu Liu; Jie Zheng
Journal:  Angew Chem Int Ed Engl       Date:  2017-12-05       Impact factor: 15.336

3.  Kinetics and dissolution of intratracheally administered nickel oxide nanomaterials in rats.

Authors:  Naohide Shinohara; Guihua Zhang; Yutaka Oshima; Toshio Kobayashi; Nobuya Imatanaka; Makoto Nakai; Takeshi Sasaki; Kenji Kawaguchi; Masashi Gamo
Journal:  Part Fibre Toxicol       Date:  2017-11-28       Impact factor: 9.400

4.  Categorization of nano-structured titanium dioxide according to physicochemical characteristics and pulmonary toxicity.

Authors:  Naoki Hashizume; Yutaka Oshima; Makoto Nakai; Toshio Kobayashi; Takeshi Sasaki; Kenji Kawaguchi; Kazumasa Honda; Masashi Gamo; Kazuhiro Yamamoto; Yasuhiro Tsubokura; Shozo Ajimi; Yoshiyuki Inoue; Nobuya Imatanaka
Journal:  Toxicol Rep       Date:  2016-05-20

5.  Brain Inflammation, Blood Brain Barrier dysfunction and Neuronal Synaptophysin Decrease after Inhalation Exposure to Titanium Dioxide Nano-aerosol in Aging Rats.

Authors:  Clémence Disdier; Monique Chalansonnet; François Gagnaire; Laurent Gaté; Frédéric Cosnier; Jérôme Devoy; Wadad Saba; Amie K Lund; Emilie Brun; Aloïse Mabondzo
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

6.  Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products.

Authors:  Ying-Fei Yang; Wei-Ming Wang; Chi-Yun Chen; Tien-Hsuan Lu; Chung-Min Liao
Journal:  Int J Nanomedicine       Date:  2019-03-05

Review 7.  Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors.

Authors:  Ting Sun; Yiyuan Kang; Jia Liu; Yanli Zhang; Lingling Ou; Xiangning Liu; Renfa Lai; Longquan Shao
Journal:  J Nanobiotechnology       Date:  2021-04-16       Impact factor: 10.435

Review 8.  Ultrasmall Luminescent Metal Nanoparticles: Surface Engineering Strategies for Biological Targeting and Imaging.

Authors:  Xiaoxi Luo; Jinbin Liu
Journal:  Adv Sci (Weinh)       Date:  2021-11-19       Impact factor: 16.806

9.  A review on potential neurotoxicity of titanium dioxide nanoparticles.

Authors:  Bin Song; Jia Liu; Xiaoli Feng; Limin Wei; Longquan Shao
Journal:  Nanoscale Res Lett       Date:  2015-08-26       Impact factor: 4.703

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.